Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue

Fatigue is the most common symptom of MS and has no effective pharmacotherapy. To determine the tolerability, safety, and efficacy of low-dose ketamine infusion for MS-related fatigue. In this double-blind, randomized, active-placebo-controlled trial, 18 subjects with multiple sclerosis (MS) and rep...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Multiple sclerosis Jg. 27; H. 6; S. 942
Hauptverfasser:	Fitzgerald, Kathryn C, Morris, Bridget, Soroosh, Aurash, Balshi, Alexandra, Maher, Dermot, Kaplin, Adam, Nourbakhsh, Bardia
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 01.05.2021
Schlagworte:	Double-Blind Method Fatigue - drug therapy Fatigue - etiology Humans Ketamine - adverse effects Multiple Sclerosis - complications Multiple Sclerosis - drug therapy Pilot Projects Treatment Outcome Multiple sclerosis fatigue ketamine midazolam randomized controlled trial
ISSN:	1477-0970, 1477-0970
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!